<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:"Calibri Light";
panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:0cm;
margin-left:0cm;
margin-bottom:.0001pt;
line-height:105%;
page-break-after:avoid;
font-size:16.0pt;
font-family:"Calibri Light",sans-serif;
color:#2E74B5;
mso-fareast-language:EN-US;
font-weight:normal;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
margin-top:2.0pt;
margin-right:0cm;
margin-bottom:0cm;
margin-left:0cm;
margin-bottom:.0001pt;
page-break-after:avoid;
font-size:13.0pt;
font-family:"Calibri Light",sans-serif;
color:#2E74B5;
mso-fareast-language:EN-US;
font-weight:normal;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Calibri Light",sans-serif;
color:#2E74B5;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Calibri Light",sans-serif;
color:#2E74B5;
mso-fareast-language:EN-US;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle21
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle22
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle23
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle24
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle25
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle26
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle27
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle28
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle29
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle30
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle31
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle32
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle33
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle34
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle35
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle36
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle37
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle38
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle39
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle40
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle41
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle42
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle43
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.custom-caption
{mso-style-name:custom-caption;}
span.ie-custom-caption
{mso-style-name:ie-custom-caption;}
span.EmailStyle46
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.imgclose
{mso-style-name:imgclose;}
span.EmailStyle48
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle49
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle50
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle51
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle52
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle53
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle54
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle55
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle56
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle57
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle58
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.gmaildefault
{mso-style-name:gmail_default;}
span.EmailStyle60
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle61
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle62
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle63
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle64
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle65
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle66
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle67
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle68
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle69
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle70
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle71
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle72
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle73
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle74
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle76
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1318801456;
mso-list-template-ids:-38647540;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-ZW link="#0563C1" vlink="#954F72"><div class=WordSection1><p class=MsoNormal><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse'><tr><td width=803 valign=top style='width:602.2pt;padding:0cm 5.4pt 0cm 5.4pt'><h1 style='margin-top:0cm;mso-line-height-alt:15.0pt;background:white;vertical-align:baseline'><a href="http://www.finsec.co.zw/"><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#2E74B5;mso-fareast-language:EN-ZW;text-decoration:none'><img border=0 width=871 height=306 id="Picture_x0020_7" src="cid:image004.jpg@01D68C0F.43E44600"></span></a><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#1F497D'><o:p></o:p></span></b></h1><h1 style='margin-top:0cm;line-height:15.0pt;background:white;vertical-align:baseline'><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#1F497D'><o:p> </o:p></span></b></h1><h1 style='margin-top:0cm;line-height:15.0pt;background:white;vertical-align:baseline'><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Global Coronavirus Updates, Sept 16: Vaccine could be a month away, says Trump; UK may limit testing to worst cases<o:p></o:p></span></b></h1><h1 style='margin-top:0cm;line-height:37.5pt;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black;mso-fareast-language:EN-ZW'><o:p> </o:p></span></h1><h2 style='margin-top:0cm;line-height:19.5pt;background:white;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#6B6B6B'>Global Coronavirus Updates: Globally, the cases surpassed 29.5 million as India hit 5 million infections today. The toll stands at 9.34 lakh</span><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#6B6B6B'><o:p></o:p></span></h2><p class=MsoNormal style='margin-bottom:15.0pt;line-height:14.25pt;vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:#484848'><o:p> </o:p></span></p><p class=MsoNormal><b><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Zimbabwe COVID19 Update<o:p></o:p></span></b></p><p class=MsoNormal style='margin-bottom:15.0pt;line-height:14.25pt;vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:#484848'><o:p> </o:p></span></p><p class=MsoNormal style='margin-bottom:15.0pt;line-height:14.25pt;vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:#484848'>COVID-19 Update: As at 15 September 2020, Zimbabwe had 7 576 confirmed cases, including 5 783 recoveries and 224 deaths.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:15.0pt;line-height:14.25pt;vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:#484848;mso-fareast-language:EN-ZW'><img border=0 width=803 height=1109 id="Picture_x0020_16" src="cid:image006.jpg@01D68C0F.43E44600" alt=Image></span><span style='font-family:"Verdana",sans-serif;color:#484848'><o:p></o:p></span></p><p class=MsoNormal style='vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:black'><o:p> </o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'>Coronavirus Global Updates:</span></strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'> The United Arab Emirates has granted emergency use authorisation to a Chinese coronavirus vaccine, thus becoming the third country in the world to allow an under-developed vaccine to be injected into its citizens. Boris Johnson’s government closed a coronavirus testing facility so the site can be made available to handle customs checks after the U.K. leaves the European Union’s single market and customs union.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p class=MsoNormal><span style='mso-fareast-language:EN-ZW'><img border=0 width=827 height=460 id="Picture_x0020_12" src="cid:image007.jpg@01D68C0F.43E44600" alt="https://images.indianexpress.com/2020/09/364678520.jpg"></span><o:p></o:p></p><p class=MsoNormal>A health care worker use a nasal swab to test for COVID-19 at a pop up testing site at the Koinonia Worship Center and Village in Florida. (Photo by Joe Raedle/Getty Images)<o:p></o:p></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'>While Japan’s economy is picking up slowly, New Zealand will endure a shallower recession than previously expected but the coronavirus pandemic will have a longer impact on the country’s finances, according to government projections. Israel’s cabinet backed a second national lockdown, while gatherings in the U.K. will be restricted as new cases climb at a pace not seen since May.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'>Globally, the cases surpassed 29.5 million as India hit 5 million infections today. The toll stands at 9.34 lakh<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'>Vaccine may be ready within a month: Trump</span></strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'>President Trump again raised hopes — and concern — about swift US approval for a coronavirus vaccine, saying the shot could be ready within four weeks. “The previous administration would have taken perhaps years to have a vaccine, because of the FDA and all the approvals,” Trump said. “We’re withing weeks of getting it. You know, could be three weeks, four weeks.”<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'>Singapore to pay citizens for keeping healthy</span></strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'>Apple Inc. and the Singapore government have partnered on a two-year health initiative dubbed LumiHealth, which is built around tracking and rewarding user behavior through the Apple Watch gadget and an iPhone app. As part of the plan, Singapore residents will be able to earn as much as S$380 ($280) by completing goals and tasks set within the app. Goals can be accomplished by walking or doing other exercises like swimming or yoga, and the LumiHealth app will offer personalized coaching and reminders for health screenings and immunizations.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'>Thailand welcomes tourists</span></strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'>Thailand will start issuing special visas to foreign tourists starting in October. Prime Minister Prayuth Chan-Ocha’s cabinet approved a proposal to issue visas to tourists planning to stay between 90 and 280 days in Thailand. The tourists will undergo a mandatory 14-day state quarantine on arrival at partner hotels or hospitals and follow health and safety regulations.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p class=MsoNormal style='vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm;mso-fareast-language:EN-ZW'><img border=0 width=759 height=422 id="Picture_x0020_5" src="cid:image010.jpg@01D68C0D.F520CF80" alt="https://images.indianexpress.com/2020/09/AP20232507380043.jpg"></span><span class=custom-caption><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm'> <o:p></o:p></span></span></p><p class=MsoNormal style='vertical-align:baseline'><span class=custom-caption><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm'>A group of people, some wearing masks pose for a photograph with decorations at an entrance to a upmarket mall in Bangkok, Thailand (AP)</span></span><span style='font-family:"Verdana",sans-serif;color:black'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'><o:p> </o:p></span></strong></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'>UK may limit testing to worst cases</span></strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'>The UK government warned that coronavirus tests could soon be further restricted as laboratories struggle to cope with rising demand, in a blow to businesses seeking to get more workers back to the office. Health Secretary Matt Hancock said on Tuesday he would “not shirk from decisions about prioritization” and resources would be focused on hospitals and care homes — a comment that suggests community testing will be reduced if demand continues to grow. The minister said he believed the problems in the system would take “a matter of weeks” to resolve.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p class=MsoNormal style='vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm;mso-fareast-language:EN-ZW'><img border=0 width=759 height=422 id="Picture_x0020_3" src="cid:image012.jpg@01D68C0D.F520CF80" alt="https://images.indianexpress.com/2020/09/364683075.jpg"></span><span class=custom-caption><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm'><o:p></o:p></span></span></p><p class=MsoNormal style='vertical-align:baseline'><span class=custom-caption><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm'> A coronavirus COVID-19 testing centre is pictured in a car park at Ebbsfleet International Railway Station, in Ebbsfleet, south east of London. (Photographer: Ben Stansall/AFP/Getty Images)</span></span><span style='font-family:"Verdana",sans-serif;color:black'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'><o:p> </o:p></span></strong></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'>Japan commits $165 mln to WHO’s global coronavirus vaccine programme</span></strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'>Japan said on Tuesday it has committed 17.2 billion yen ($165 million) in funds for its participation in the World Health Organization’s COVID-19 vaccine programme. The programme, known as COVAX, is aimed at helping buy and fairly distribute vaccination shots against the novel coronavirus around the world. But some countries which have secured their own supplies through bilateral deals, including the United States, have said they will not join. The funds are part of a 1.64 trillion yen reserve intended to bolster the government’s response to the virus, a government document showed.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'>Pfzier trial free of major safety issues so far</span></strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'>Researchers monitoring Pfizer Inc.’s giant trial of an experimental Covid-19 vaccine have reported no safety problems even after more than 12,000 people received their second of two doses. The trial, now targeted at enrolling 44,000 people, has reached its initial goal of 30,000 subjects, Pfizer executives said. The trial is comparing two shots of the vaccine Pfizer is co-developing with Germany’s BioNTech SE to two doses of a placebo.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p class=MsoNormal style='vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm;mso-fareast-language:EN-ZW'><img border=0 width=759 height=422 id="_x0000_i1027" src="cid:image013.jpg@01D68C0D.F520CF80" alt="https://images.indianexpress.com/2020/09/364531065.jpg"></span><span class=custom-caption><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm'><o:p></o:p></span></span></p><p class=MsoNormal style='vertical-align:baseline'><span class=custom-caption><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm'> A pedestrian wearing a protective mask passing in front of Pfizer Inc. signage is reflected outside the company’s headquarters in New York, US</span></span><span style='font-family:"Verdana",sans-serif;color:black'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'><o:p> </o:p></span></strong></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E;border:none windowtext 1.0pt;padding:0cm'>AstraZeneca’s US trial remains on hold pending review by FDA</span></strong><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline;box-sizing: border-box;outline: 0px'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'>AstraZeneca Plc’s Covid-19 vaccine study remains paused in the US pending a regulatory review of an incident in which a U.K. study participant became ill, federal officials said. Trials resumed in the U.K. over the weekend and restarted in South Africa on Tuesday. Multiple news reports in the US media said the National Institutes of Health (NIH), the US counterpart of Indian Council of Medical Research (ICMR), had launched its own investigation into the incident that had led to the halting of the trials of the AstraZeneca vaccine two weeks ago.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;line-height:21.0pt;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#3E3E3E'><o:p> </o:p></span></p><p class=MsoNormal style='vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm;mso-fareast-language:EN-ZW'><img border=0 width=818 height=454 id="Picture_x0020_1" src="cid:image009.jpg@01D68C0F.43E44600" alt="coronavirus, coronavirus latest news, india coronavirus cases, corona news, corona cases in india, india news, coronavirus news, covid 19 india, corona news, corona latest news, india coronavirus, coronavirus latest news in india, maharashtra coronavirus news, kerala coronavirus news, andhra pradesh coronavirus news"></span><span class=custom-caption><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm'><o:p></o:p></span></span></p><p class=MsoNormal style='vertical-align:baseline'><span class=custom-caption><span style='font-family:"Verdana",sans-serif;color:#747474;border:none windowtext 1.0pt;padding:0cm'> A sign featuring the AstraZeneca Plc logo stands at the company’s DaVinci building at the Melbourn Science Park in Cambridge, U.K (Photographer: Jason Alden/Bloomberg)</span></span><span style='font-family:"Verdana",sans-serif;color:black'><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;line-height:115%;vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p> </o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='text-align:justify;line-height:115%;background:white;vertical-align:baseline'><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><i><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Invest Wisely!</span></i><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Bulls n Bears <o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'> <o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Telephone: </span><span style='font-family:"Verdana",sans-serif'><a href="tel:%2B263%204%202927658" target="_blank"><span style='color:windowtext;mso-fareast-language:EN-ZW'>+263 4 2927658</span></a></span><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Cellphone: </span><span style='font-family:"Verdana",sans-serif'><a href="tel:%2B263%2077%20344%201674" target="_blank"><span style='color:windowtext;mso-fareast-language:EN-ZW'>+263 77 344 1674</span></a></span><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Alt. Email: </span><span style='font-family:"Verdana",sans-serif'><a href="mailto:info@bulls.co.zw"><span style='color:windowtext;mso-fareast-language:EN-ZW'>info@bulls.co.zw</span></a></span><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'> <o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Website: </span><span style='font-family:"Verdana",sans-serif'><a href="http://www.bullszimbabwe.com"><span style='mso-fareast-language:EN-ZW'>www.bullszimbabwe.com</span></a></span><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'> <o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Blog: </span><span style='font-family:"Verdana",sans-serif'><a href="http://www.google.com/url?q=http%3A%2F%2Fwww.bulls.co.zw%2Fblog&sa=D&sntz=1&usg=AFQjCNFoIy6F9IXAiYnSoPSgWDYsr8Sqtw" target="_blank"><span style='color:#1F497D;mso-fareast-language:EN-ZW'>www.bullszimbabwe.com</span><span style='color:windowtext;mso-fareast-language:EN-ZW'>/blog</span></a></span><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Twitter: @bullsbears2010<o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>LinkedIn: Bulls n Bears Zimbabwe<o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;background:white'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Facebook: </span><span style='font-family:"Verdana",sans-serif'><a href="http://www.google.com/url?q=http%3A%2F%2Fwww.facebook.com%2FBullsBearsZimbabwe&sa=D&sntz=1&usg=AFQjCNGhb_A5rp4biV1dGHbgiAhUxQqBXA" target="_blank"><span style='color:windowtext;mso-fareast-language:EN-ZW'>www.facebook.com/BullsBearsZimbabwe</span></a></span><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'>Skype: Bulls.Bears <o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><img border=0 width=210 height=101 id="Picture_x0020_2" src="cid:image019.jpg@01D675FB.3A851690" alt="cid:image012.jpg@01D0BFE7.544DF490"></span><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr></table></div><p class=MsoNormal><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></div></body></html>